Acadian Asset Management LLC Jounce Therapeutics, Inc. Transaction History

Acadian Asset Management LLC

$32.2 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$0.9 - $1.85 $866,253 - $1.78 Million	-962,504 Reduced 87.67%	135,324 $249,000
Q4 2022 Feb 14, 2023	BUY	$0.64 - $1.99 $191,003 - $593,901	298,443 Added 37.33%	1,097,828 $1.22 Million
Q3 2022 Nov 14, 2022	SELL	$2.73 - $4.92 $59,901 - $107,954	-21,942 Reduced 2.67%	799,385 $1.87 Million
Q2 2022 Aug 09, 2022	BUY	$2.8 - $7.67 $8,327 - $22,810	2,974 Added 0.36%	821,327 $2.49 Million
Q1 2022 May 12, 2022	SELL	$6.01 - $8.54 $461,994 - $656,478	-76,871 Reduced 8.59%	818,353 $5.56 Million
Q4 2021 Feb 10, 2022	BUY	$7.11 - $9.64 $48,767 - $66,120	6,859 Added 0.77%	895,224 $7.47 Million
Q3 2021 Nov 12, 2021	BUY	$5.04 - $8.73 $929,607 - $1.61 Million	184,446 Added 26.2%	888,365 $6.6 Million
Q2 2021 Aug 11, 2021	BUY	$6.58 - $10.66 $1.44 Million - $2.33 Million	218,774 Added 45.09%	703,919 $4.79 Million
Q1 2021 May 11, 2021	SELL	$6.73 - $13.87 $454,160 - $935,989	-67,483 Reduced 12.21%	485,145 $4.98 Million
Q4 2020 Feb 11, 2021	SELL	$6.37 - $10.33 $1.93 Million - $3.12 Million	-302,494 Reduced 35.37%	552,628 $3.87 Million
Q3 2020 Nov 09, 2020	SELL	$4.58 - $10.95 $524,693 - $1.25 Million	-114,562 Reduced 11.81%	855,122 $6.98 Million
Q2 2020 Aug 12, 2020	BUY	$4.17 - $7.58 $46,983 - $85,403	11,267 Added 1.18%	969,684 $6.69 Million
Q1 2020 May 11, 2020	BUY	$2.91 - $8.7 $811,712 - $2.43 Million	278,939 Added 41.05%	958,417 $4.55 Million
Q4 2019 Feb 06, 2020	BUY	$2.81 - $9.21 $730,085 - $2.39 Million	259,817 Added 61.91%	679,478 $5.93 Million
Q3 2019 Nov 07, 2019	BUY	$3.33 - $4.93 $145,091 - $214,805	43,571 Added 11.59%	419,661 $1.4 Million
Q2 2019 Aug 08, 2019	BUY	$4.3 - $6.73 $363,595 - $569,068	84,557 Added 29.0%	376,090 $1.86 Million
Q1 2019 May 09, 2019	BUY	$3.43 - $6.87 $519,905 - $1.04 Million	151,576 Added 108.3%	291,533 $1.81 Million
Q4 2018 Feb 07, 2019	BUY	$2.69 - $6.71 $213,225 - $531,874	79,266 Added 130.61%	139,957 $471,000
Q3 2018 Oct 30, 2018	BUY	$6.5 - $8.37 $247,559 - $318,779	38,086 Added 168.48%	60,691 $395,000
Q2 2018 Jul 24, 2018	SELL	$7.27 - $21.88 $467,439 - $1.41 Million	-64,297 Reduced 73.99%	22,605 $173,000
Q1 2018 Apr 12, 2018	SELL	$13.4 - $28.4 $2.1 Million - $4.46 Million	-157,054 Reduced 64.38%	86,902 $1.94 Million
Q4 2017 Jan 18, 2018	SELL	$12.52 - $17.82 $917,603 - $1.31 Million	-73,291 Reduced 23.1%	243,956 $3.11 Million
Q3 2017 Oct 13, 2017	BUY	$11.17 - $16.99 $3.54 Million - $5.39 Million	317,247	317,247 $4.94 Million

Others Institutions Holding JNCE

# of Institutions

Shares Held

720K

Call Options Held

Put Options Held

View Full List

About Jounce Therapeutics, Inc.

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

More about JNCE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Account